Title : Phase I/II trial of human recombinant beta-interferon serine in patients with renal cell carcinoma.

Pub. Date : 1986 Oct

PMID : 3756886






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Beta-interferon serine (IFN-beta ser) is a genetically altered recombinant IFN with a specific activity of 2 X 10(8) IU/mg protein. Serine interferon beta 1 Homo sapiens
2 Beta-interferon serine (IFN-beta ser) is a genetically altered recombinant IFN with a specific activity of 2 X 10(8) IU/mg protein. Serine interferon beta 1 Homo sapiens
3 IFN-beta ser was given by a 4-h intravenous infusion twice weekly (Monday and Thursday). Serine interferon beta 1 Homo sapiens
4 We conclude that IFN-beta ser is a well tolerated IFN with minimal renal, hepatic, and bone marrow toxicity. Serine interferon beta 1 Homo sapiens